Securities code: Cansino Biologics Inc(688185) securities abbreviation: Cansino Biologics Inc(688185) Announcement No.: 2022019 Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company
Special report on the deposit and actual use of raised funds in 2021
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company (hereinafter referred to as “the company”) the board of directors in accordance with the relevant provisions of China Securities Regulatory Commission (hereinafter referred to as “CSRC”) “guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds of listed companies (revised in 2022)” and “guidelines for the self discipline supervision of listed companies on the science and Innovation Board of Shanghai Stock Exchange No. 1 – standardized operation”, A special report on the deposit and actual use of the funds raised by the initial public offering of A-Shares as of December 31, 2021 (hereinafter referred to as the “report on the deposit and actual use of the raised funds”) has been prepared. The deposit and actual use of the raised funds as of December 31, 2021 are described as follows:
1、 Basic information of raised funds
With the approval of the reply on Approving the registration of Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company’s initial public offering of shares (Zheng Jian FA FA FA Zi [2020] No. 1448 document) issued by the CSRC, the company publicly issued 24800000 RMB ordinary shares (A shares) at the Shanghai Stock Exchange, with the issuing price of 209.71 yuan per share and the total amount of funds raised from the stock issuance of 520080800000 yuan, After deducting all share issuance expenses (excluding value-added tax, including underwriting and recommendation expenses and other issuance expenses) of RMB 22134289235, the net amount of actually raised funds was RMB 497946510765, of which the amount of over raised funds was RMB 397946510765. All the above funds were received on August 6, 2020, It has been verified by PwC Zhongtian Certified Public Accountants (special general partnership) and issued PwC Zhongtian Yan Zi (2020) No. 0684 capital verification report.
As of December 31, 2021, the company used 279406291656 yuan of raised funds (excluding cash management of idle raised funds), and the balance of unused raised funds was 21897127344 yuan; The net amount of interest income and cash management income of raised funds received by the company after deducting bank charges is RMB 12811866080, and the balance of raised funds is RMB 231783142424, including RMB 174000000000 for cash management.
As of December 31, 2021, in addition to the amount of RMB 174000000000 used for cash management, the balance of the company’s special account for raised funds is RMB 57783142424 (including the interest income of raised funds and cash management income minus the net amount of bank charges).
2、 Deposit and management of raised funds
(I) formulation and implementation of fund-raising management system
In order to standardize the management of the company’s raised funds and protect the rights and interests of investors, the management system of Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company’s raised funds is formulated in accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the Listing Rules of Shanghai Stock Exchange on the science and innovation board, the measures for the management of raised funds of listed companies on Shanghai Stock Exchange and other relevant laws and regulations, and in combination with the actual situation of the company, Provisions are made on the storage, use, change, management and supervision of the raised funds, and a special account management is implemented for the raised funds.
(II) signing and implementation of tripartite supervision agreement for raised funds
On July 22, 2020, the company and Citic Securities Company Limited(600030) (hereinafter referred to as the “sponsor”) signed the tripartite supervision agreement on the storage of special account for raised funds (hereinafter referred to as the “tripartite supervision agreement”) with Bank Of China Limited(601988) Tianjin Binhai Branch, Shanghai Pudong Development Bank Co.Ltd(600000) Tianjin Branch, China Merchants Bank Co.Ltd(600036) Tianjin branch and China Citic Bank Corporation Limited(601998) Tianjin branch respectively.
(III) storage of raised funds in special account
As of December 31, 2021, the ending balance of the bank account of the company’s raised funds totaled 57783142424 yuan, including the accumulated bank deposit interest and cash management product income of 12811866080 yuan (after deducting the bank handling fee). This amount does not include the balance of idle raised funds for cash management of the company as of December 31, 2021. For details of using idle raised funds for cash management, please refer to part III of this report. Actual use of raised funds this year (IV) cash management of idle raised funds and investment in related products. The specific storage conditions are as follows:
Unit: RMB
Save
Name of deposit bank account number of deposit company deposit balance agreement signed by the name Party of the supervision department on December 31, 2021
Bank Of China Limited(601988) Co., Ltd. Tianjin Development Co., Ltd. 3669745779 agreement of phase 281790532726 of the company
West District sub branch
Agreement on 14985182107 of phase 772 Sichuan Dawn Precision Technology Co.Ltd(300780) 17 Ping An Bank Co.Ltd(000001) 085 of Shanghai Pudong Development Yinhuo tripartite supervision Bank Co., Ltd
Tianjin Science and technology sub branch
29586982507 agreement of Shanghai Pudong Development Yinhuo tripartite supervision Bank Co., Ltd. for phase 772 Citic Press Corporation(300788) 019 Ping An Bank Co.Ltd(000001) 084 of the company
Tianjin Branch
China Merchants Bank Co.Ltd(600036) joint stock living third party Supervision Co., Ltd. Tianjin new technology company 122905456610202 phase 2901708362 agreement
Technology Industrial Park sub branch
China Merchants Bank Co.Ltd(600036) joint stock active third party Supervision Co., Ltd. Tianjin new technology company 122905456610506 phase 4822491109 agreement
Technology Industrial Park sub branch
China Citic Bank Corporation Limited(601998) Co., Ltd. Binhai New Area Co., Ltd. 36581889 agreement for phase 8111401012700554921 of the company
Branch Sales Department
China Citic Bank Corporation Limited(601998) joint stock active third party Supervision Co., Ltd. Binhai New Area company 8111401012900554922 phase 1780450671 agreement
Branch Sales Department
Total 57783142424
3、 Actual use of raised funds this year
(I) use of funds for investment projects with raised funds
As of December 31, 2021, in addition to cash management of idle raised funds, the company has used the funds raised from the initial public offering of A-Shares of RMB 279406291656.
For the specific use of the raised funds, see the attached table comparison table of the use of the funds raised by the initial public offering of A-Shares in this report.
(II) early investment and replacement of raised investment projects
As of December 31, 2021, the company has not replaced the self raised funds of the projects invested in advance with the raised funds.
(III) temporary replenishment of working capital with idle raised funds
As of December 31, 2021, the company has not used idle raised funds to temporarily supplement working capital.
(IV) cash management of idle raised funds and investment in related products
In order to improve the use efficiency of the company’s idle raised funds and enhance the ability of the raised funds to obtain income, the company held the second meeting of the second board of directors and the second meeting of the second board of supervisors on August 21, 2020 in accordance with the regulatory guidelines for listed companies No. 2 – regulatory requirements for the management and use of raised funds of listed companies and other relevant systems and norms of the CSRC, The proposal on the use of temporarily idle raised funds for cash management was reviewed and approved, and the company was agreed to use temporarily idle raised funds up to RMB 500 million to timely purchase investment products with high security, good liquidity and principal guaranteed agreement (including but not limited to principal guaranteed financial products, structured deposits, call deposits, time deposits, large certificates of deposit, etc.) with a service life of no more than 12 months, Within the above limit and term, it can be used circularly. The board of directors authorizes the chairman of the company to exercise investment decision-making power and sign relevant documents within the validity of the above quota and resolution. The specific matters shall be organized and implemented by the Finance Department of the company.
In order to improve the use efficiency of the raised funds of the company, without affecting the construction of the raised funds and the normal operation of the company, the company will reasonably use some idle raised funds for cash management, increase capital income and obtain investment return for the company and its shareholders. The company held the sixth meeting of the second board of directors and the eighth meeting of the second board of supervisors on August 27, 2021, deliberated and adopted the proposal on cash management with temporarily idle raised funds, and agreed that the company would use temporarily idle raised funds up to RMB 35000 million to timely purchase with high safety, good liquidity Investment products with Principal Guaranteed agreements (including but not limited to principal guaranteed financial products, structured deposits, call deposits, time deposits, certificates of deposit, etc.) have a service life of no more than 12 months and can be recycled and rolled within the above limit and term. The board of directors authorizes the chairman of the company to exercise investment decision-making power and sign relevant documents within the validity of the above quota and resolution. The specific matters shall be organized and implemented by the Finance Department of the company.
As of December 31, 2021, the balance of idle funds raised by the company’s initial public offering under cash management was RMB 174000000000. The total investment income of the company from cash management with idle raised funds in this year was 4488653652 yuan.
As of December 31, 2021, the outstanding cash management products held by the company are as follows:
No. trustee type amount (yuan) start and end time income type expected annualized income
China Citic Bank Corporation Limited(601998) share structure breakeven floating in November 2021
1. Binhai deposit of Co., Ltd. 30000000000 June 20 – revenue type 3.25% new area branch business
Department February 2022
18th
China Citic Bank Corporation Limited(601998) shares November 2021
2. Binhai structural Co., Ltd. 14000000000 on 30th – breakeven floating
New area branch business deposit February 28, 2022 revenue type 3.10% Department
Shanghai Pudong Development Bank Co.Ltd(600000) Tianjin structure November 2021
3 700,00
